>
The System Being Built While the World Burns
As Epstein's Clients Walk Free, an Innocent Man Rots in a Cage for Promoting Liberty
Federal Appeals Court Allows Pentagon To Designate Anthropic As A Supply-Chain Risk
Artemis II Astronauts Prepare For Re-Entry, Splashdown
Anthropic says its latest AI model is too powerful for public release and that it broke...
The CIA used a futuristic new tool called "Ghost Murmur" to find and rescue...
This Plant Replaces All Fertilizer FOREVER. Why Did the FDA Ban It?
China Introduces Pistol-Like Coil-Gun Based On Electromagnetic-Launch Systems
NEXT STOP: MARS IN JUST 30 DAYS?!
Poland's researchers discovered a bacteria strain that destroys pancreatic cancer.
Intel Partners with Tesla and SpaceX on Terafab
Anthropic Number One AI in Ranking and Revenue - Making $30 Billion Per Year
India's indigenous fast breeder reactor achieves critical stage: PM Modi

Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.